- $213.95bn
- $210.76bn
- $19.41bn
- 100
- 16
- 72
- 66
2019 November 29th | 2020 November 27th | 2021 December 3rd | 2022 December 2nd | 2023 December 1st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,171 | 12,868 | 15,785 | 17,606 | 19,409 |
Cost of Revenue | |||||
Gross Profit | 9,499 | 11,146 | 13,920 | 15,441 | 17,055 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7,903 | 8,631 | 9,983 | 11,508 | 12,759 |
Operating Profit | 3,268 | 4,237 | 5,802 | 6,098 | 6,650 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,205 | 4,176 | 5,705 | 6,008 | 6,799 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,954 | 5,260 | 4,822 | 4,756 | 5,428 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,951 | 5,260 | 4,822 | 4,756 | 5,428 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,951 | 5,260 | 4,822 | 4,756 | 5,428 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.33 | 11.1 | 10 | 10.1 | 11.8 |